Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR)

[1]  P. Ferrone,et al.  Topical Dexamethasone as an Adjuvant to Mineralocorticoid Receptor Antagonists for the Treatment of Recalcitrant Central Serous Chorioretinopathy. , 2022, Ophthalmic surgery, lasers & imaging retina.

[2]  J. Zi,et al.  First Evidence Indicates the Physiology- and Axial-Myopia-Dependent Profiles of Steroid Hormones in Aqueous Humor , 2022, Metabolites.

[3]  I. Mantel,et al.  Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men , 2022, Journal of Clinical Medicine.

[4]  Min Zhao,et al.  Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues , 2022, International journal of molecular sciences.

[5]  Min Zhao,et al.  Mineralocorticoid pathway in retinal health and diseases , 2021, British journal of pharmacology.

[6]  S. Sivaprasad,et al.  Validation of central serous chorioretinopathy multimodal imaging-based classification system , 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.

[7]  C. Gomez-Sanchez,et al.  11βHSD2 Efficacy in Preventing Transcriptional Activation of the Mineralocorticoid Receptor by Corticosterone. , 2021, Journal of the Endocrine Society.

[8]  Y. Arsenijévic,et al.  Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium , 2021, International journal of molecular sciences.

[9]  Min Zhao,et al.  Mineralocorticoid Receptor Pathway and Its Antagonism in a Model of Diabetic Retinopathy , 2021, Diabetes.

[10]  R. Pellegrino,et al.  Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application , 2021, International journal of clinical practice.

[11]  B. Gong,et al.  Genetic associations of central serous chorioretinopathy: a systematic review and meta-analysis , 2021, British Journal of Ophthalmology.

[12]  S. Sivaprasad,et al.  Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders , 2021, Progress in Retinal and Eye Research.

[13]  A. Sehgal,et al.  A circadian clock regulates efflux by the blood-brain barrier in mice and human cells , 2021, Nature Communications.

[14]  Serge Rudaz,et al.  From a single steroid to the steroidome: Trends and analytical challenges , 2020, The Journal of Steroid Biochemistry and Molecular Biology.

[15]  F. Behar-Cohen,et al.  Choroidal imaging in patients with Cushing syndrome , 2020, Acta ophthalmologica.

[16]  J. Chhablani,et al.  Multimodal Imaging-Based Central Serous Chorioretinopathy Classification. , 2020, Ophthalmology. Retina.

[17]  O. Dekkers,et al.  Hair cortisol concentrations in chronic central serous chorioretinopathy , 2020, Acta ophthalmologica.

[18]  S. Kishi,et al.  Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum Diseases. , 2020, Ophthalmology. Retina.

[19]  F. Behar-Cohen,et al.  Angiotensin II and aldosterone: Co-conspirators in ocular physiology and disease. , 2020, Experimental eye research.

[20]  T. Ogihara,et al.  Testosterone and androstenedione are endogenous substrates of P-glycoprotein. , 2019, Biochemical and biophysical research communications.

[21]  Ge Ge,et al.  Corticosteroids usage and central serous chorioretinopathy: a meta-analysis , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[22]  Todd E. Scheetz,et al.  Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration , 2019, Proceedings of the National Academy of Sciences.

[23]  F. Drago,et al.  Ocular Pharmacological Profile of Hydrocortisone in Dry Eye Disease , 2019, Front. Pharmacol..

[24]  Min Zhao,et al.  Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: Review of the pre-clinical and clinical evidence. , 2019, Experimental eye research.

[25]  J. Jais,et al.  Effect of acute and chronic aldosterone exposure on the retinal pigment epithelium-choroid complex in rodents. , 2019, Experimental eye research.

[26]  Priyatham S. Mettu,et al.  Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms. , 2019, Experimental eye research.

[27]  Su-Qin Yu,et al.  Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy. , 2019, Ophthalmology.

[28]  C. Rivolta,et al.  Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration , 2019, Nature Communications.

[29]  J. Schepers,et al.  Validity and time course of surgical fear as measured with the Surgical Fear Questionnaire in patients undergoing cataract surgery , 2018, PloS one.

[30]  Karthik Yadav Janga,et al.  Retina Compatible Interactions and Effective Modulation of Blood Ocular Barrier P-gp Activity by Third-Generation Inhibitors Improve the Ocular Penetration of Loperamide. , 2018, Journal of pharmaceutical sciences.

[31]  Michael J. Keiser,et al.  Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior. , 2017, Cell reports.

[32]  Kimitoshi Nakamura,et al.  A comparison of sex steroid concentration levels in the vitreous and serum of patients with vitreoretinal diseases , 2017, PloS one.

[33]  S. Kabanarou,et al.  Risk Factors for Central Serous Chorioretinopathy: Multivariate Approach in a Case-Control Study , 2017, Current eye research.

[34]  M. Lombès,et al.  Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method , 2017, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  D. Léger,et al.  Shift Work: A Risk Factor for Central Serous Chorioretinopathy. , 2016, American journal of ophthalmology.

[36]  Min Zhao,et al.  Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis , 2015, Progress in Retinal and Eye Research.

[37]  E. Karahan,et al.  Correlation of choroidal thickness with serum cortisol level , 2015, Clinical & experimental optometry.

[38]  K. Green,et al.  Ocular pharmacokinetics of fluocinolone acetonide following Iluvien implantation in the vitreous humor of rabbits. , 2015, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[39]  Lei Liu,et al.  Cortisol Biosynthesis in the Human Ocular Surface Innate Immune Response , 2014, PloS one.

[40]  Peng Chen,et al.  Expression of Efflux Transporters in Human Ocular Tissues , 2013, Drug Metabolism and Disposition.

[41]  C. Pariante,et al.  Changes in the Brain Accumulation of Glucocorticoids in abcb1a-Deficient CF-1 Mice , 2012, Journal of neuroendocrinology.

[42]  A. Agrotis,et al.  The retinal renin–angiotensin system: Roles of angiotensin II and aldosterone , 2012, Peptides.

[43]  S. Whitcup,et al.  Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. , 2010, Investigative ophthalmology & visual science.

[44]  C. Pariante,et al.  A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild-type and ABCB1A/B-deficient mice. , 2008, Endocrinology.

[45]  R. Sharma,et al.  Expression of molecular equivalent of hypothalamic-pituitary-adrenal axis in adult retinal pigment epithelium. , 2007, The Journal of endocrinology.

[46]  H. Takanaga,et al.  Blood—Brain Barrier Is Involved in the Efflux Transport of a Neuroactive Steroid, Dehydroepiandrosterone Sulfate, via Organic Anion Transporting Polypeptide 2 , 2000, Journal of neurochemistry.

[47]  W. Rosner,et al.  Effect of protein binding on transfer and metabolism of cortisol in perfused human placenta. , 1978, The Journal of clinical endocrinology and metabolism.

[48]  S. Bakri,et al.  Central serous chorioretinopathy and glucocorticoids: an update on evidence for association. , 2018, Survey of ophthalmology.

[49]  E. Kasimov,et al.  [Cortisol levels in plasma and aqueous humour of patients with steroid induced and other glaucomas]. , 2017, Vestnik oftalmologii.